The Evolving Role of Tau in Neurodegeneration
A comprehensive look at biomarkers and clinical applications
Whitepaper
Tau is emerging as a critical biomarker in Alzheimer’s disease, advancing early diagnosis, prognosis, and treatment monitoring.
This whitepaper explores:
- Key Tau biomarkers (p-Tau 181, p-Tau 217, p-Tau 231)
- Cutting-edge detection methods in blood, CSF, and brain imaging
- The impact of Tau biomarkers on Alzheimer’s research and clinical applications
Download now to explore the latest advancements